TLC Provides Corporate Update at Investor Conference – Dec 18, 2020,

TLC590 demonstrated more pain relief than the active comparator in both a soft tissue setting (Phase I/II clinical trial in hernia repair surgery) as well as a …, TLC590 demonstrated more pain relief than the active comparator in both a soft tissue setting (Phase I/II clinical trial in hernia repair surgery) as well as a …, Read More